Home » Depo Provera Lawsuit for Brain Tumor Risk
Attorney Sean T. Keith has been a personal injury lawyer for 30+ years, a nationally recognized Top 100 Trial Lawyer, and top car accident lawyer & motor vehicle accident lawyer in Arkansas.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and attorneys at Keith Law Group and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Sean T. Keith, you can do so here.
Keith Law Group does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us. This article should not be taken as advice from an attorney.
On this page, we’ll discuss the Depo Provera Lawsuit for Brain Tumors, the role of a lawyer in determining eligibility and seeking compensation in Depo Provera Lawsuits, information on the scientific findings concerning the development of brain tumors related to Depo Provera usage, and much more.
The Depo-Provera contraceptive injection has been linked to an increased risk of developing intracranial meningiomas, a type of brain tumor.
Recent studies have shown that women who use Depo-Provera for more than 12 months face a significantly higher risk of developing these tumors, which, although typically benign, can lead to serious and potentially life threatening health issues if left untreated.
Symptoms of meningiomas include headaches, seizures, and vision problems, often requiring surgery for removal.
Researchers have highlighted that the risk of meningiomas rises with prolonged use of Depo-Provera, prompting concerns about the drug’s safety for long-term users.
Despite these risks, Pfizer, the manufacturer of Depo-Provera, has only recently begun updating warning labels to reflect the potential danger.
Warning labels in Europe and the United Kingdom have been updated to include the risk of brain tumors, but warning labels in the United States have not yet been changed.
Legal action is being taken by individuals who have suffered from these complications, with lawsuits alleging that Pfizer Inc. failed to adequately warn users of the risks.
If you or a loved one developed brain tumors after taking Depo Provera injections, you may be eligible to file a Depo Provera Lawsuit and seek compensation.
Contact the Depo Provera Lawyers at Keith Law Group for a free consultation.
You can also use the the chatbot on this page for a free case evaluation to find out if you qualify for the Depo Provera Brain Tumor Lawsuit instantly.
It is the responsibility of pharmaceutical companies to ensure that their products are safe for consumers and to provide adequate warnings about any potential risks associated with their use.
In the case of Depo-Provera, plaintiffs in ongoing lawsuits allege that Pfizer failed to properly warn users about the increased risk of developing brain tumors after prolonged use.
The Depo-Provera Shot Lawsuit seeks compensation for medical expenses, pain and suffering, and other damages resulting from the serious side effects linked to the contraceptive injection.
Plaintiff attorneys have moved to consolidate all Depo-Provera lawsuits into a federal multidistrict litigation (MDL).
The claims center on allegations that Depo-Provera, a hormonal contraceptive containing medroxyprogesterone acetate, dramatically raises the risk of brain tumors, with studies showing a fivefold increase in risk among users.
The lawsuits allege that the drug’s manufacturers failed to provide sufficient warnings about these risks to both patients and healthcare providers.
Many women affected by the drug have required invasive brain surgeries and now suffer from lasting complications such as vision impairment, seizure disorders, and permanent neurological injuries.
On November 26, plaintiffs filed a motion with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate 22 active lawsuits from eight district courts.
They proposed the Northern District of California as the venue, as it already hosts six of the pending cases.
According to the motion, centralizing the cases is critical to managing the nearly identical claims efficiently, ensuring consistent rulings, and avoiding redundant legal work.
The plaintiffs also anticipate a rapid expansion of the litigation, with more women expected to file similar lawsuits in the near future.
If the JPML approves the motion, the MDL will allow all current and future Depo-Provera lawsuits to be overseen by a single judge, enabling coordinated pretrial processes like discovery and legal motions.
If you or a loved one developed a brain tumor after using Depo-Provera, you may be entitled to seek compensation through a Depo-Provera Lawsuit.
Keith Law Group is currently accepting new clients.
Contact our experienced Depo-Provera Lawyers for a free consultation, or use the chatbot on this page to determine if you qualify for a claim instantly.
November 27, 2024
A motion to consolidate the Depo-Provera lawsuits into a single multidistrict litigation (MDL) has been submitted to the Judicial Panel on Multidistrict Litigation (JPML) by the plaintiffs.
With 22 cases currently in progress, they propose the U.S. District Court for the Northern District of California as the preferred venue, citing its history of handling high-profile MDLs like Roundup.
The motion will be discussed at a hearing on December 5, 2024, and the JPML is not expected to address the litigation until 2025.
If consolidation is approved, it could set the stage for the first major mass tort of the year.
Plaintiffs assert that an MDL is vital to managing the complex litigation surrounding Depo-Provera, which includes claims of severe side effects like meningiomas caused by extended use of the contraceptive shot.
Defendants, however, are likely to contest the motion and may seek to move the proceedings to a District Court in New York instead.
If you or a loved one developed a brain tumor after using Depo-Provera, you may be entitled to seek compensation through a Depo-Provera Lawsuit.
Keith Law Group is currently accepting new clients.
Contact our experienced Depo-Provera Lawyers for a free consultation, or use the chatbot on this page to determine if you qualify for a claim instantly.
November 15, 2024
Lawsuits allege that Depo-Provera, a prescription contraceptive produced by the defendants, led to serious injuries, with scientific studies linking medroxyprogesterone acetate (MPA), its active ingredient, to the development of meningiomas.
Analysis of a database indicated that the injectable form of MPA increases the likelihood of developing meningiomas by 53%, with the risk rising with longer use.
Furthermore, data from 2004 to 2015 show significant increases in meningioma diagnoses, particularly among women, African Americans, and younger individuals.
Plaintiffs argue that the defendants were aware of these risks for years but failed to provide warnings to patients and healthcare providers in the U.S.
Unlike the U.S., the European and Canadian labels for Depo-Provera now include meningioma warnings.
Warnings associated with Depo-Provera include:
If you or a loved one developed a brain tumor after using Depo-Provera, you may be entitled to seek compensation through a Depo-Provera Lawsuit.
Keith Law Group is currently accepting new clients.
Contact our experienced Depo-Provera Lawyers for a free consultation, or use the chatbot on this page to determine if you qualify for a claim instantly.
The Depo-Provera lawsuit is ongoing.
Depo-Provera Lawsuits are progressing in federal courts, with more than 30 cases anticipated by the end of November.
The majority of these filings are focused in the Northern District of California and the Southern District of Texas.
An important Judicial Panel on Multidistrict Litigation (JPML) hearing is scheduled for December 5, 2024, to review the potential for case consolidation.
An official MDL is unlikely to be established before the end of the year.
MDLs are formed when there are at least 25 related cases addressing common issues and involving similar defendants across federal courts.
This threshold is expected to be reached in the ongoing Depo-Provera litigation.
Plaintiffs are anticipated to advocate for consolidation in California, while defendants may oppose and propose New York as an alternative venue for coordination.
If you or a loved one developed a brain tumor after using Depo-Provera, you may be entitled to seek compensation through a Depo-Provera Lawsuit.
Keith Law Group is currently accepting new clients.
Contact our experienced Depo-Provera Lawyers for a free consultation, or use the chatbot on this page to determine if you qualify for a claim instantly.
The Depo-Provera lawsuit is ongoing.
A recent lawsuit filed in the U.S. District Court for the Central District of California accuses the makers of Depo-Provera of failing to warn about potential brain tumor risks.
The case involves a California woman who claims her nearly 25 years of using the birth control shot led to the development of a meningioma brain tumor.
Defendants in the case include Pfizer, Viatris, Greenstone, Prasco, and Pharmacia & Upjohn.
The lawsuit states that the plaintiff began receiving Depo-Provera injections in 2000, totaling 91 doses over her treatment period.
By 2020, she experienced symptoms such as headaches, blurred vision, vertigo, and ear itching, which led to the discovery of a calcified meningioma brain tumor.
Due to the tumor’s state, surgical removal is considered too risky, resulting in ongoing pain and symptoms.
The plaintiff’s complaint argues that the companies involved failed to properly investigate or warn users in the U.S. about the risks of long-term Depo-Provera use, despite these warnings being present on Canadian labels since 2015.
This case joins a growing number of similar lawsuits being filed across the United States.
If you or a loved one developed a brain tumor after using Depo-Provera, you may be entitled to seek compensation through a Depo-Provera Lawsuit.
Contact the dedicated Depo-Provera Lawyers at Keith Law Group for a free consultation.
Use the chatbot on this page to instantly check your eligibility to file a claim.
The Depo-Provera lawsuits have spotlighted legal complexities surrounding the statute of limitations in these cases.
However, two primary reasons suggest that the statute of limitations should not pose a significant barrier for individuals filing claims related to Depo-Provera injuries at this time.
First, many states recognize the “discovery rule,” which can extend the statute of limitations.
This rule delays the clock on filing a lawsuit until the injured party becomes aware of both the injury and its connection to a specific cause.
In Depo-Provera cases, recent scientific studies have identified a possible link between the drug and brain tumors, a connection that was not widely known before now.
Since this information has only recently come to light, plaintiffs could not have reasonably connected their medical conditions to Depo-Provera until recently.
Secondly, the doctrine of fraudulent concealment may also come into play.
Under this doctrine, if a defendant has intentionally hidden important safety information, the statute of limitations can be paused.
Plaintiffs allege that the manufacturers of Depo-Provera deliberately concealed the drug’s risks by downplaying or manipulating safety warnings and product labels, making it difficult for users to understand the potential connection between the drug and meningiomas.
This alleged concealment means plaintiffs can argue they were prevented from discovering the risks, further extending the timeframe for filing lawsuits.
The combination of the discovery rule and fraudulent concealment could provide a solid legal basis for plaintiffs to overcome statute of limitations challenges in the Depo-Provera lawsuits, giving them time to pursue their claims.
If you or a loved one developed a brain tumor after using Depo-Provera, you may be entitled to seek compensation through a Depo-Provera Lawsuit.
Our lawyers are still accepting new clients.
Contact our Depo-Provera Lawyers today for a free consultation, or use the chatbot on this page to find out if you qualify for a claim instantly.
Depo-Provera is a widely used injectable contraceptive containing the hormone medroxyprogesterone acetate, a synthetic form of the hormone progestin.
This hormone prevents pregnancy by inhibiting ovulation and thickening cervical mucus, meaning it stops the ovaries from releasing eggs and makes it more difficult for sperm to travel through the cervix and reach an egg.
Depo Provera is administered as a birth control shot every three months.
This makes Depo Provera a popular choice for women who who want long-term but reversible birth control without taking daily pills.
There are two formulations of Depo-Provera, including Depo-SubQ Provera 104, a lower-dose version that is injected just under the skin rather than into the muscle.
Both versions are effective at preventing pregnancy and are sometimes prescribed to manage conditions like endometriosis.
However, while Depo-Provera offers convenience and effectiveness, its long-term use has been associated with potentially serious side effects and health risks, such as bone density loss and an increased risk of developing brain tumors.
It’s essential to discuss these potential risks with a healthcare provider when considering Depo-Provera as a contraceptive method.
Depo-Provera is manufactured by Pfizer Inc., one of the largest pharmaceutical companies in the world.
Depo Provera was initially approved by the FDA in 1992 for use as a contraceptive injection.
Pfizer is also responsible for distributing the lower-dose version, Depo-SubQ Provera 104.
Depo-Provera users face several potential health risks, especially when the contraceptive is used long-term.
One of the most serious concerns is the significant loss of bone mineral density, which can lead to osteoporosis and increase the risk of fractures.
Studies have also linked prolonged use of Depo-Provera to an elevated risk of developing intracranial meningiomas, a type of brain tumor that can cause severe symptoms such as headaches, vision issues, and seizures.
Other reported side effects include weight gain, mood changes, and an increased risk of blood clots, which can lead to life-threatening conditions like pulmonary embolism or stroke.
Given these risks, it is crucial for users to regularly consult with their healthcare provider to evaluate whether the benefits of Depo-Provera outweigh the potential health complications.
Recent studies published in The British Medical Journal (BMJ) and other peer-reviewed journals have identified a significant link between long-term use of Depo-Provera and the development of intracranial meningiomas, a type of brain tumor.
While these tumors are typically benign, they can cause severe complications such as headaches, vision issues, and seizures if left untreated.
Meningiomas are typically benign but can cause serious complications if left untreated, including severe headaches, vision issues, and seizures.
The risk of developing these tumors increases with prolonged use of Depo-Provera, particularly in women who have been using the contraceptive for two or more years.
Key scientific findings include:
These findings are crucial for anyone considering long-term use of Depo-Provera, as the potential for brain tumors is a serious concern.
As of 2024, the U.S. label for Depo-Provera does not include a warning about the increased risk of brain tumors, such as intracranial meningiomas.
While the European Union and the United Kingdom have updated their labels to reflect this risk, the U.S. version has not yet incorporated this information.
Pfizer has only indicated that it plans to update the label in the future.
Intracranial meningiomas are tumors that form in the meninges, the protective layers surrounding the brain and spinal cord.
These tumors are typically slow-growing and are classified as benign in most cases, meaning they are not cancerous.
However, their location in the brain can still cause serious complications, as they can press against brain structures and nerves, leading to neurological symptoms.
Intracranial meningiomas account for approximately 40% of all primary brain tumors, making them one of the most common types.
While the exact cause of meningiomas is not always clear, certain factors such as prolonged use of hormone therapies like Depo-Provera have been linked to an increased risk of developing these tumors.
Women who develop intracranial meningiomas linked to Depo-Provera usage often experience a variety of symptoms based on the size and location of the tumor.
These symptoms may range from mild to severe and can worsen if the tumor is left untreated.
Early detection is critical to managing the condition, as treatment may prevent further complications.
Common symptoms of Depo-Provera brain tumors include:
Diagnosing intracranial meningiomas typically begins with a detailed medical history and physical examination, particularly if symptoms like headaches, vision changes, or seizures are present.
The first step in confirming the presence of a brain tumor is usually imaging tests, such as a magnetic resonance imaging (MRI) scan, which provides detailed images of the brain and can reveal the size and location of the tumor.
A computed tomography (CT) scan may also be used, especially if MRI is unavailable or further confirmation is needed.
In some cases, a biopsy may be performed, where a small sample of the tumor is taken for examination under a microscope to determine whether it is benign or malignant.
Blood tests may also be conducted to rule out other conditions that could be causing similar symptoms.
Doctors often use these diagnostic tools to assess the tumor’s growth rate and its potential impact on surrounding brain structures.
Once a diagnosis is confirmed, a treatment plan is developed based on the tumor’s size, location, and the patient’s overall health.
Intracranial meningiomas, though often benign, can still pose significant health risks depending on their size and location in the brain.
Treatment for these tumors largely depends on their growth rate, symptoms, and potential impact on brain function.
Smaller, asymptomatic tumors may simply be monitored through regular imaging tests, while larger or symptomatic meningiomas usually require more aggressive treatment.
Surgical removal is often the primary treatment for meningiomas that cause symptoms or grow rapidly.
Radiation therapy may be used either after surgery to eliminate remaining tumor cells or as a primary treatment if surgery isn’t feasible.
Some patients may also benefit from newer, targeted therapies, though these are generally still under investigation.
Common treatment options for intracranial meningiomas include:
Treatment plans are tailored to each patient’s specific needs, and the potential risks of each option are carefully weighed against the benefits.
Although most intracranial meningiomas are benign, their location in the brain can lead to serious complications if left untreated.
The long-term effects depend on the size and location of the tumor and the treatment method used, which can result in permanent damage to brain functions.
Some patients may experience lasting neurological impairments, such as memory issues, difficulty with motor skills, or persistent headaches.
Treatment options like surgery or radiation therapy can carry risks of further complications, including infections, brain swelling, or cognitive changes.
Common complications and long-term effects include:
Addressing these complications early through proper diagnosis and treatment is essential to managing long-term effects.
Women who took Depo Provera and were later diagnosed with a brain tumor, specifically meningioma, may be eligible to file a lawsuit.
To qualify, you must meet specific criteria, including length of Depo Provera use, number of times the shot was used, and a specific injury diagnosis.
Each state has a time limit to file a claim called the statute of limitations, so it’s essential to contact an attorney right away to preserve your legal right to file a claim.
Experienced lawyers can help you through the legal process, completing the crucial steps of gathering evidence and assessing damages.
Gathering strong evidence is essential to building a successful case in a Depo-Provera Lawsuit.
This evidence will help demonstrate the link between the contraceptive and serious health issues such as brain tumors, supporting your claim for compensation.
Your lawyer can assist in gathering the necessary documentation.
Possible types of evidence for a Depo Provera Lawsuit include:
Collecting this evidence early will strengthen your case and help establish the direct connection between your health issues and Depo-Provera use.
Damages in a Depo-Provera lawsuit refer to the compensation that plaintiffs may be entitled to for the physical, emotional, and financial losses they have suffered as a result of using the drug.
These damages are intended to make up for the harm caused by serious health conditions, such as brain tumors, that are linked to the contraceptive.
Types of damages that may be pursued in a Depo-Provera Lawsuit:
Claims filed are designed to help individuals recover from the financial, physical, and emotional toll caused by using Depo-Provera.
The injectable form of birth control, Depo-Provera, is used by countless women across the country for its convenience and long-lasting effects.
However, recent studies have shown a significant link between prolonged use of Depo-Provera and an increased risk of developing brain tumors, specifically intracranial meningiomas.
These tumors, while often benign, can still cause serious health complications, such as headaches, vision problems, seizures, and neurological impairment.
In some cases, surgical removal of the tumor is necessary, which carries its own risks, including permanent brain damage or cognitive impairments.
If you have suffered brain tumors after taking Depo Provera contraceptive injections, you may be eligible to file a Depo Provera Lawsuit and seek compensation.
Contact the Depo Provera Lawyers at Keith Law Group for a free consultation.
Use the chatbot on this page for a free case evaluation to find out if you qualify for the Depo Provera Lawsuit instantly.
The Depo-Provera birth control shot works by delivering a synthetic hormone called medroxyprogesterone acetate, which mimics the effects of the hormone progesterone.
It primarily prevents pregnancy by stopping ovulation, which means it prevents the ovaries from releasing eggs.
Additionally, it thickens cervical mucus, making it more difficult for sperm to travel through the cervix and fertilize an egg.
The shot also thins the lining of the uterus, reducing the likelihood of a fertilized egg implanting.
Depo-Provera is administered once every three months and provides long-term contraception without the need for daily pills.
The statute of limitations for filing a Depo-Provera lawsuit varies depending on the state where the claim is filed.
Most states have a time limit of two to three years from the date of injury or discovery of the injury to file a claim.
However, some states may allow more time under specific circumstances, such as if the injury was discovered much later.
It is critical to consult with an attorney as soon as possible to ensure that you file within the appropriate timeframe, as missing the statute of limitations could result in losing the right to seek compensation.
Always verify the specific statute in your state to avoid missing important legal deadlines.
No, there is not a class action lawsuit for brain and spinal cord tumors associated with Depo Provera usage.
Depo Provera Lawsuits may be consolidated into multidistrict litigation (MDL), a federal legal procedure that allows for the grouping of individual lawsuits that seek individualized compensation based on based on common issues.
Each plaintiff in an MDL retains their own case and seeks individualized compensation based on the specific damages they suffered.
Unlike class actions, where all plaintiffs share the same outcome and any settlement is divided equally, MDL cases allow for separate trials to address unique damages and outcomes for each plaintiff.
The advantage of MDL is that it streamlines pretrial procedures and evidence gathering while ensuring that plaintiffs still receive compensation tailored to their individual injuries.
Many product liability lawsuits, including those involving Depo-Provera, follow the MDL process to efficiently handle large numbers of similar cases while preserving individual claims.
Women may choose Depo-Provera over other forms of birth control for several reasons, including its convenience and unique medical benefits.
One of the primary advantages of Depo-Provera is that it is administered as a shot every three months, which eliminates the need to take a daily pill or use other frequent methods like patches or rings.
This can be particularly helpful for women who prefer a low-maintenance form of contraception.
In addition to contraception, Depo-Provera has medical benefits for women with conditions like endometrial hyperplasia.
Since it contains the hormone progestin (medroxyprogesterone acetate), Depo-Provera helps thin the uterine lining, reducing the risk of developing endometrial hyperplasia, which is a condition characterized by the abnormal thickening of the uterine lining and can lead to endometrial cancer if untreated.
For women at risk of this condition, Depo-Provera offers a protective benefit by counteracting the effects of excess estrogen on the uterine lining.
Women who experience heavy, painful periods or irregular periods also find that Depo-Provera can lessen menstrual flow or even stop menstruation altogether, which may significantly improve their quality of life.
However, while Depo-Provera is effective in preventing pregnancy and managing these conditions, it comes with potential risks, including bone mineral density loss and an increased risk of brain tumors, which should be discussed with a healthcare provider before starting the medication.